Article
A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry
1 Aug 2017
Abstract excerpt
Angelman syndrome (AS) is a rare neurodevelopmental disorder that is characterised by severe global developmental delays, ataxia, loss of speech, epilepsy, sleep disorders, and a happy disposition. There is currently no cure for AS, though several pharmaceutical companies are anticipating drug trials for new therapies to treat AS. The Foundation for Angelman Therapeutics (FAST) Australia therefore identified a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
